금융 뉴스 허브

1 Reason to Avoid ADUS and 1 Stock to Buy Instead

Over the past six months, Addus HomeCare’s shares (currently trading at $98.51) have posted a disappointing 11.1% loss, well below the S&P 500’s 10% gain. This was partly due to its softer quarterly r ...

BlackRock weighs multibillion-dollar investment in SpaceX IPO, the Information reports

BlackRock has discussed investing $5 billion to $10 billion in SpaceX's ‌initial public offering next month, the ‌Information news outlet reported on Saturday, citing people ​familiar with the matter. ...

Warren Buffett Has Been Saying This for Years. 1 Vanguard ETF Puts That Advice Into Practice.

Warren Buffett often advocates for low-cost, value-oriented investing. But over the years, he's specifically advocated for one Vanguard ETF in particular.

A Historical Double Whammy Makes a Stock Market Crash More Likely Under President Donald Trump

As the Dow, S&P 500, and Nasdaq Composite ascend to the heavens, so does the likelihood of the Trump bull market taking the elevator down.

Alfreton Capital Sees Opportunity in CCC, Buys 1.98M Shares

This technology firm delivers SaaS and AI-driven workflow solutions for leading players in the property and casualty insurance sector.

Review & Preview: AI Isn’t Forever

All three major indexes stumbled on Friday as inflation worries and geopolitical concerns dampened market optimism.

ChargePoint Holdings, Inc. (CHPT) Suffers a Larger Drop Than the General Market: Key Insights

ChargePoint Holdings, Inc. (CHPT) closed at $6.63 in the latest trading session, marking a -2.64% move from the prior day.

MicroStrategy is "more than cash, equity, debt," says Phong Le, yet MSTR falls

Synopsys (SNPS) Registers a Bigger Fall Than the Market: Important Facts to Note

Synopsys (SNPS) concluded the recent trading session at $501.52, signifying a -1.67% move from its prior day's close.

Sandisk Soars 482% As AI Memory Boom Slashes Valuation Multiples

Sandisk and Micron trade below nine times forward earnings despite surging AI-driven demand for memory chips.

Outlook Therapeutics Non-GAAP EPS of -$0.16 misses by $0.04, revenue of $0.13M misses by $4.27M

This ‘safe haven’ bond is projected to pay 5.1% this year — with almost no risk

The April 2032 inflation-protected U.S. TIPS bond looks like a pretty good deal.